AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 59 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,006,737 | -89.1% | 291,938 | -81.3% | 0.00% | -90.9% |
| Q4 2022 | $45,764,344 | +70.9% | 1,561,923 | -3.3% | 0.01% | +83.3% |
| Q3 2022 | $26,786,000 | +7.6% | 1,615,578 | +1.5% | 0.01% | 0.0% |
| Q2 2022 | $24,883,000 | -14.8% | 1,592,009 | -0.1% | 0.01% | 0.0% |
| Q1 2022 | $29,207,000 | +55.1% | 1,593,376 | -0.3% | 0.01% | +50.0% |
| Q4 2021 | $18,835,000 | -41.9% | 1,597,479 | +0.2% | 0.00% | -42.9% |
| Q3 2021 | $32,410,000 | -8.6% | 1,594,813 | -1.2% | 0.01% | -12.5% |
| Q2 2021 | $35,472,000 | – | 1,614,998 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $8,193,050 | 18.42% |
| TCG Crossover Management, LLC | 2,201,274 | $29,871,288 | 4.40% |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27,672,609 | 4.29% |
| Sofinnova Investments, Inc. | 3,758,686 | $51,005,369 | 3.22% |
| GREAT POINT PARTNERS LLC | 1,091,233 | $14,808,032 | 2.70% |
| RA Capital Management | 8,263,982 | $112,142,236 | 2.21% |
| Cormorant Asset Management, LP | 1,561,696 | $21,192,215 | 1.24% |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $16,350,045 | 1.09% |
| Octagon Capital Advisors LP | 497,370 | $6,749,311 | 1.04% |
| Ghost Tree Capital, LLC | 201,197 | $2,730,243 | 0.90% |